The LIBERATE trial, recently published on the American Journal of Respiratory and Clinical Care Medicine, demonstrated that treating severe emphysema with endobronchial valves (EBVs) improves lung function, exercise tolerance and quality of life a year after treatment. The EBVs approach resulted in a less invasive method with minimally complications compared to lung volume reduction surgery (LVRS).

“ASK THE EXPERT” is now available to registered users. This service will help physicians to find a second opinion on patient’s medical diagnosis and choose the best treatment. Three simple steps to ensure your second opinion:

• Register to www.breathgroup.eu
• Select one of the proposed Experts and submit your request
• Receive Expert’s opinion

The First “Investigator’s Meeting Breathgroup” will take place in Milan the 19-20 January 2018.

The meeting gives the opportunity to all participating Centers to discuss on study protocol, introduce the Registry and the electronic Case Report Form (e-CRF) and show all the functions related to the website.

The new National Register on patient management with severe emphysema undergoing bronchoscopic pulmonary therapy has been opened.